PAINCEPTOR PHARMA
PainCeptor Pharma is a pharmaceutical company developing next generation therapeutic drugs for the treatment of chronic and acute pain. PainCeptor's therapeutic programs are concentrated on some of the most promising, novel, yet scientifically validated therapeutic targets within the PNS (peripheral nervous system). By focusing on modulating target receptors in the PNS, PainCeptor expects to enhance the efficacy and avoid the many detrimental side effects associated with today's pain drugs which act primarily in the CNS (central nervous system). PainCeptor's development pipeline includes two lead antagonist programs, targeting NGF/p75-TrkA and ASIC1a, and a third antagonist program targeting ASIC3.
PAINCEPTOR PHARMA
Industry:
Medical Pharmaceutical Therapeutics
Founded:
2004-01-01
Address:
Saint-laurent, Manitoba, Canada
Country:
Canada
Website Url:
http://www.painceptor.com
Total Employee:
1+
Status:
Active
Total Funding:
37.92 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Pound Sterling Japanese Yen Baidu Analytics
Similar Organizations
CorneaCare
Personalized dry eye treatment delivered and monitored.
Investors List
Lothian Partners
Lothian Partners investment in Series B - PainCeptor Pharma
Desjardins Venture Capital
Desjardins Venture Capital investment in Series B - PainCeptor Pharma
Business Development Bank of Canada
Business Development Bank of Canada investment in Series B - PainCeptor Pharma
CDP Capital Technology Ventures
CDP Capital Technology Ventures investment in Series B - PainCeptor Pharma
CDP Capital Technology Ventures
CDP Capital Technology Ventures investment in Series A - PainCeptor Pharma
